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Iron deficiency in children is associated with a number of neural defects including hypomyelination. It has been
hypothesized by others that this hypomyelination is due to a failure in myelin production. Other possibilities include failure
in the generation of oligodendrocytes from their precursor cells or an interruption in oligodendrocyte maturation. These
hypotheses are based on the observations that there is a peak in brain iron uptake in vivo that coincides with the period of
reatest myelination and that a shortage of iron leads to myelination deficiency. We now demonstrate that iron availability
odulates the generation of oligodendrocytes from tripotential-glial restricted precursor (GRP) cells isolated from the
mbryonic day 13.5 rat spinal cord. In contrast, we found no effects of iron on oligodendrocyte maturation or survival in
itro, nor did we find that increasing iron availability above basal levels increases oligodendrocyte generation from
ipotential oligodendrocyte-type-2 astrocyte/oligodendrocyte precursor cells (O-2A/OPCs). Our results raise the possibility
hat iron may affect oligodendrocyte development at stages during early embryogenesis rather than during later
evelopment. © 2001 Academic Press
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aINTRODUCTION
The most common nutrient deficiency in the world is a
lack of iron. It has been estimated that 35–58% of women
have some degree of iron deficiency and the occurrence of
iron deficiency during pregnancy is even higher (Fairbanks,
1994). It has been also reported that for children under 2
years of age, the estimated prevalence of iron deficiency is
25% (deMaeyer and Adiels-Tegman, 1985; Florentino and
Guirriec, 1984). Iron deficiency in children is associated
with a number of neural defects including behavioral ef-
fects, alterations to the blood brain barrier, changes in fatty
acid composition, and hypomyelination (Dobbing, 1990;
Honig and Oski, 1978; Pollitt and Leibel, 1976; Yu et al.,
1986). It is not completely understood when and by what
mechanisms these defects are manifested (Dobbing, 1990;
Honig and Oski, 1978; Pollitt and Leibel, 1976).
In the central nervous system, myelin, the material
1 To whom correspondence should be addressed. Fax: 716-273-
d1450. E-mail: margot_mayer-proschel@urmc.rochester.edu.
232esponsible for insulation of axonal processes to enable
altatory conduction to occur, is produced by specialized
ells called oligodendrocytes. It has been noted that when
he brains of many different species are histochemically
abeled for iron, the cells with the highest iron levels are
ligodendrocytes (Benkovic and Connor, 1993; Connor et
l., 1990; Dwork et al., 1988; Hill and Swizter, 1984; Levine
nd Macklin, 1990; Morris et al., 1992).
The time point at which the maximum amount of myelin
s being produced coincides with a peak period of iron influx
nto the brain and cerebrospinal fluid (schematized in Fig. 1)
Crowe and Morgan, 1992; Jacobson, 1963; Skoff et al.,
976; Taylor and Morgan, 1990). It has been suggested that
his increase in iron uptake is a necessary step to proceed
hrough gliogenesis and is tightly linked with the normal
roduction of myelin in the brain (Connor and Menzies,
996; Larkin and Rao, 1990).
Consistent with this suggestion are results obtained with
ron-deficient and myelin-deficient animal models. For ex-
mple, Larkin and colleagues demonstrate that iron-
eficient animals, where any peak in iron uptake into the
0012-1606/01 $35.00
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233Effect of Iron of Embryonic Glial Differentiationbrain would be greatly attenuated, show lowered levels of
myelin lipids (Larkin and Rao, 1990). However, the myelin
isolated from these iron-deficient animals is normal in the
ratios of its myelin components, suggesting that the myelin
produced in iron-deficient rats is normal but that the
amount generated is greatly reduced (Larkin and Rao, 1990).
These findings are also consistent with past in vitro experi-
ments where rat oligodendrocyte progenitor cells were
exposed to transferrin-enriched medium leading to an in-
crease in the number of surviving oligodendrocytes after 7
days (Eccleston and Sliberberg, 1984). Whether this increase
is due to an alteration of the rate of differentiation or
represents a direct effect of transferrin on survival is not
addressed in this study. The availability of sufficient iron
and normal myelination also appear to be linked in hu-
mans, which has been indicated by measuring auditory
brainstem responses (ABRs), where changes in the latency
of the ABRs are an indicator of axonal myelination (Hecox,
1982; Jiang, 1995; Salamy and McKean, 1976). A recent
study has shown that there are measurable differences in
ABR latency between normal and iron-deficient children
(Roncagliolo et al., 1998). These changes may represent a
efect in the myelination processes of the iron-deficient
hildren.
Consistent with the view that iron deficiency and myeli-
ation might be functionally linked processes are studies
FIG. 1. Relationship between iron uptake in to the cerebral spina
ptake into the brain are adapted from Taylor and Morgan (Crowe an
, embryonic day; P, postnatal age in days. Below this is a schemat
f differentiation in the oligodendroglial lineage.n myelin-deficient animals. For example, Roskams and l
Copyright © 2001 by Academic Press. All rightonnor show that in myelin-deficient rats, in which oligo-
endrocytes fail to mature, the levels of transferrin in the
rain are well below normal levels. This suggests that less
ron is available to cells and this may be causing or
nitiating the defect in myelin production (Roskams and
onnor, 1990). It has further been demonstrated that expo-
ure of these myelin-deficient rats to exogenous transferrin
an promote the production of myelin (Escobar Cabrera et
l., 1994).
While all of these observations provide circumstantial
vidence suggesting that a peak of iron uptake into the
rain during oligodendrocyte generation is necessary for
ormal oligodendrocyte and myelin production, it is still
ot clear whether this increase in iron is directly linked to
liogenesis. Specifically, the questions of whether the tim-
ng of this peak period in iron uptake is critical for myelin
roduction and whether the absence of this peak period
ffects normal gliogenesis remain unanswered. One way to
nderstand in more detail the role of iron in oligodendro-
yte development is to take advantage of the detailed
nformation available regarding the generation of this type
f cell in vitro (see Fig. 2 for a schematic overview of what
s currently known about the oligodendrocyte lineage).
The precursor cell that gives rise to oligodendrocytes was
rst discovered in 1983 by Raff, Miller, and Noble (Raff et
l., 1983a) and has been extensively studied by many
d and brain and the timing of myelination. Data for timing of iron
organ, 1992). Immediately beneath is a rat developmental timeline.
presentation of the relationship between cell types and the timingl flui
d M
ic reaboratories. These precursor cells are referred in the litera-
s of reproduction in any form reserved.
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234 Morath and Mayer-Pro¨schelture as either oligodendrocyte-type-2 astrocyte (O-2A) pro-
genitor cell or oligodendrocyte precursor cells (OPC cells).
We will here use the term O-2A/OPC to reflect both terms
used in the literature. The O-2A/OPC can be readily grown
in vitro as a purified cell population, thus enabling direct
analysis of each of the conditions of interest in this study
(e.g., Barres et al., 1994a; Ibarrola et al., 1996; Mayer et al.,
994). Moreover, a number of mitogens and cell–cell inter-
ctions that regulate cell division and differentiation in this
ineage have been identified, thus allowing for easy in vitro
anipulation (e.g., Barres et al., 1994b, 1996; Bogler et al.,
990; Ibarrola et al., 1996; Noble et al., 1988).
The O-2A/OPCs isolated from the CNS or spinal cord of
erinatal animals are not the only cell type of relevance to
ligodendrocyte generation. We thus far know of two addi-
ional developmental steps (each representing still another
istinct precursor cell population) that also are potential
ontributors to the existence of critical developmental
eriods. We have shown that another glial-restricted pre-
ursor cell (GRP cell) exists prior to the appearance of
-2A/OPC. GRP cells can be directly isolated from E13.5
mbryos (Rao et al., 1998), and are distinct from O-2A/OPC
ells in their survival requirements, their antigenic pheno-
ype, and most notably their differentiation potential. We
ave recently found that the GRP cell can itself give rise to
-2A/OPCs, and this developmental step seems to be
equired in the generation of oligodendrocytes from GRP
ells (Gregori et al., unpublished observation). The GRP cell
s itself derived from a totipotent neuroepithelial stem cell
NSC), which can give rise to all of the cell types of the CNS
FIG. 2. Diagrammatic view of the relationship between different
precursor cells and differentiated cell types of the CNS. Heavier
arrows indicate the generation of a lineage-restricted precursor cell
while lighter arrows indicate the currently understood derivation
of a differentiated cell type.Rao and Mayer-Proschel, 1997). Having identified various
Copyright © 2001 by Academic Press. All rightrecursor cells that can contribute to the generation of
ligodendrocytes, it seems possible that iron deficiency
ould impair oligodendrocyte generation already at the
mbryonic stage by altering the division, differentiation, or
urvival of GRP cells and/or of O-2A/OPCs present in the
mbryonic CNS.
We now demonstrate that iron availability modulates the
eneration of oligodendrocytes from tripotential GRP cells
solated from the E13.5 rat spinal cord. In contrast, we
ound no effects of iron availability above basal levels on
he generation of oligodendrocytes from bipotential O-2A/
PCs, nor did we find that increasing iron affects matura-
ion or survival of postmitotic oligodendrocyte. This was a
urprising result as it is not consistent with the hypoth-
sized role of the iron availability during the peak period of
yelination. Thus, our results raise the possibility that iron
ay affect oligodendrocyte development at stages during
arly embryogenesis rather than during later development.
MATERIALS AND METHODS
Preparation of Cell Cultures
Cultures of purified O-2A/OPCs were prepared from the corpus
callosum of 7-day-old Sprague–Dawley rats. Single-cell suspensions
were prepared by treating the tissue with 36 units/ml papain
(Worthington Biochemical Corp.) for 1.5 h in an incubator (37°C,
7.5% CO2) followed by mechanical dissociation using 21-, 25-, and
6-gauge needles. Purification of O-2A/OPCs by immunopanning
as performed as previously described (Mayer et al., 1994). After
lating, the final percentage of A2B52 cells was less than 1.0%.
Purified O-2A/OPCs were plated onto either Poly-L-lysine (PLL;
Sigma; 175,000 Mr 20 mg/ml)-coated 75-cm2 flasks or onto PLL-
coated 12-mm glass coverslips in Dulbeco’s modified Eagle’s me-
dium (DME; Gibco BRL) supplemented with 25 mg/ml gentamycin
Gibco BRL), 2 mM glutamine (Gibco BRL), 1 mg/ml bovine
ancreas insulin (Sigma), 0.0286% (v/v) BSA Path-O-Cyte 4, 0.2 mM
rogesterone (Sigma), 0.10 mM putrescine (Sigma), 0.4 mM sele-
nium (Sigma), 100 mg/ml apo-transferrin (Sigma) as modified from
Bottenstein and Sato (1979). Coverslips were plated at a density of
3,000 cells and flasks were typically seeded with 500,000 cells. The
type and concentration of growth factors added depended on the
individual experiment. The growth factors that were used were:
platelet derived growth factor-a (PDGF; Peprotech) and basic fibro-
blast growth factor (bFGF; Peprotech).
Cultures of purified glial restricted precursors were isolated from
the spinal cords of E13.5 Sprague–Dawley rats as previously de-
scribed (Rao et al., 1998). In brief, the dissected spinal cords were
ubjected to 0.25% trypsin, 1 nM EDTA solution (Gibco BRL) for 3
in. This was followed by mechanical dissociation using a 25-
auge needle. Cells were immediately negatively immunopanned
o remove all embryonic NCAM (E-NCAM)-positive cells. This
as immediately followed by a positive immunopanning for A2B5
ells. The resultant population was then plated in flasks or on
overslips coated with 20 mg/ml fibronectin and 5 mg/ml laminin
(Sigma). The culture media used was DME/F12 containing the
modified Bottenstein and Sato ingredients as outlined in the
culture of O-2A/OPCs.
Pure cultures of immature or mature oligodendrocytes were
obtained by plating purified O-2A/OPCs on PLL-coated cell culture
s of reproduction in any form reserved.
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235Effect of Iron of Embryonic Glial Differentiationmaterial and culturing them in DME-BS supplemented with 45 nM
l-triiodothyronine (T3; Sigma) for 3–5 days. The purity of the
culture was examined by immunocytochemistry using antibodies
to A2B5, GFAP, and GalC.
Time-Lapse Microcinematography
O-2A/OPCs from the corpus collosum were plated into T-75
flasks coated with PLL and cultured in DME-BS containing 10
ng/ml PDGF. After the cells were allowed to adhere to the flask,
they were placed in a heated (37°C), humidified, CO2-regulated
(7.5%) chamber built into the stage of a specially converted Zeiss
Axiovert 135 TV. Images were taken at an interval of 1 per second
by using a Photometrics Image Point cooled CCD video camera and
a Panasonic AG-6730 time-lapse video cassette recorder.
Immunocytochemistry
All antibodies were diluted in staining media consisting of Hanks’
balanced salt solution (Sigma) containing 0.05% w/v sodium azide
(Sigma), 5% heat-inactivated donor calf serum (Gibco) buffered to pH
7.4 with Hepes (Sigma) prior to use, and applied to cells for 20 min.
Antibodies to cell surface antigens were applied directly to living
cells. To permeabilize cells for internal antigens, cells were incubated
at 220°C for 5 min in methanol that had previously been cooled to
20°C. After antibody staining, coverslips were washed three times
n distilled water and mounted facedown in a drop of anti-fade (2.5%
/v 1,4-diazabicyclo(2.2.2)octane in glycerol) to prevent the loss of
uorescence and sealed with clear nail finish. Specimens were viewed
ith a Zeiss Axiophot microscope equipped with phase-contrast
ptics, epiflourescent illumination, and selective filters for rhoda-
ine, fluorescein, and coumarin.
The following antibodies were used in this study: A2B5 mouse
gM monoclonal antibody (Eisenbarth et al., 1979) was prepared as
ybridoma supernatant and used at a dilution of 1:1. This antibody
ecognizes a variety of gangliosides including GQ1c, GT3, GQ1b, and
certain derivatives of these gangliosides (Dubois et al., 1990). A
mouse IgG3 monoclonal antibody against galactocerebroside
GalC)(Ranscht et al., 1982), a specific label for oligodendrocytes
Raff et al., 1978), was prepared as hybridoma supernatant and used
t a dilution of 1:1. The antiserum for myelin basic protein (MBP)
as purchased from Biomeda and used at a dilution of 1:10. All
uorescein- and rhodamine-conjugated secondary layer antibodies
ere purchased from Southern Biotechnology Associates and were
sed at a dilution of 1:100.
BrdU Incorporation Assay
To determine whether cells were synthesizing DNA, cultures
were incubated for 8 h in the presence of 10 mM
5-bromodeoxyuridine (BrdU; Sigma). The incorporation into the
nuclei of those cells that synthesized DNA was visualized by using
anti-BrdU antibody (Gratzner, 1982). Prior to the application of
anti-BrdU antibody, the cells were stained with the A2B5 antibody
and an appropriate rhodamine-conjugated second-layer antibody as
described above. Cells were then fixed in methanol (5 min, 220°C)
and first exposed to 0.02% paraformaldehyde for 1 min and then to
0.07 M NaOH for 7 min. Coverslips were rinsed several times in
staining media and incubated with anti-BrdU antibodies for 20
min. After several washings, the cells were incubated with a
fluorescein-conjugated goat anti-mouse-IgG1 for 20 min. Cover-
slips were then washed, mounted, and examined as described in the
immunocytochemistry section.
Copyright © 2001 by Academic Press. All rightWestern Blot Analysis
Protein extracts were made by using an NP40 lysis buffer and
total protein content was determined by using a Sigma protein
assay kit. Lanes containing equal amounts of protein were sepa-
rated by using SDS–PAGE and then blotted to nitrocellulose.
Western blots were performed as previously described (Halow and
Lane, 1998) by using the following antibodies: anti-myelin basic
protein MCA686 (Serotec), anti-CNPase C-5922 (Sigma Immuno-
Chemicals), and anti-PLP (a kind gift from Dr. Mark Noble).
Immunocomplexes were visualized by using HRP-conjugated sec-
ondary antibodies appropriated to the primary antibody (Sigma,
1:50,000) and chemiluminescence detection (Renaissance, NEN
Life Sciences). The bands were visualized and quantified with a
Lumi-Imager luminometer available from Boehringer Mannheim.
Atomic Adsorption Spectroscopy
Cell cultures were generated as outlined in Preparation of Cell
Cultures. Cultures were then treated 1/2 100 ng/ml Fe1 in form of
ferric ammonium citrate for 24 h prior to lysis. Protein extracts
were made by using an NP40 lysis buffer and total protein content
was determined by using a Sigma protein assay kit. Equal amounts
of protein for each sample were loaded into a Perkin Elmer Optima
3100 XL atomic adsorption spectroscopy machine to determine the
total soluble iron concentration of the samples.
RESULTS
In order to examine the role of increased iron availability
on gliogenesis, we established culture conditions that
would mimic the increase in iron availability that is
thought to occur in vivo. The comparable iron level we used
in our studies was designed to resemble the levels found in
the cerebrospinal fluid at the time of greatest myelination
(50 6 37 ng/ml) (Gruener et al., 1991). We chose for our
studies an iron concentration that is higher than the con-
centration found in vivo but is not toxic to the cells studied.
As a defined baseline medium, we used the same medium
utilized by the majority of investigators containing a base-
line concentration of 14 ng/ml iron. It should be empha-
sized that in all experiments where we did not add addi-
tional iron, the iron concentration is 14 ng/ml.
In the first series of experiments, we determined the
optimal dose of iron that would represent a high iron
concentration but would not influence the viability of the
cells. Iron is known to be toxic through its ability to
participate in reactions that generate free radicals and can
therefore lead to considerable cell death. Specifically quan-
tifying survival of precursor cells over a number of days in
various iron concentrations proved to be difficult due to the
ongoing proliferation and differentiation events of the pre-
cursor cells. To separate the effects of iron on survival from
any effect iron might have on proliferation and differentia-
tion, we chose a condition that would neither allow cell
proliferation nor differentiation into oligodendrocytes. In
accordance with published data (McKinnon et al., 1993;
Noble et al., 1988), we grew O-2A/OPC cells in defined
medium supplemented with 0.1 ng/ml PDGF in the ab-
s of reproduction in any form reserved.
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236 Morath and Mayer-Pro¨schelsence of thyroid hormone (T3, a molecule shown to pro-
mote differentiation of precursor cells into oligodendro-
cytes) 6 100 ng/ml iron. The optimal condition to study
urvival of GRP cells proved to be growth of cells in a
edium devoid of T3 and supplemented with 1 ng/ml
FGF 6 100 ng/ml iron. The presence of bFGF was neces-
ary as GRP cells do not express the PDGF-a receptor and
are FGF-dependent for survival. The concentration of 1
ng/ml bFGF was low enough to inhibit differentiation
without causing proliferation. To determine the tolerance
of oligodendrocytes to high iron concentration, oligoden-
drocytes were derived from O-2A/OPC cells as described in
Materials and Methods and exposed to medium 6 100
ng/ml iron. The survival of the various cells was deter-
mined by using MTT, a substance that can only be con-
verted into a visible product by the mitochondria of living
cells. The number of living GRP cells and O-2A/OPC cells
was examined after 2 days and the number of living oligo-
dendrocytes was examined after 5 days. Iron levels in the
culture media were manipulated by the addition of ferric
ammonium citrate, which is known to have the ability to
modulate the iron regulatory machinery within the cell
(Guo et al., 1994; Phillips et al., 1996). Transferrin, known
to modulate the generation of oligodendrocytes, was
present in all cultures as iron-free apo-transferrin. The
levels of apo-transferrin were identical in both control and
high iron conditions because we were interested in studying
the effects of iron and not transferrin. As shown in Fig. 3,
we could see no difference in the number of living cells
FIG. 3. Iron is not toxic to GRP cells, O-2A-progenitor cells, or
mature oligodendrocytes. Freshly dissected GRP and O-2A/OPCs
were plated on coverslips into basic survival conditions specific to
the cell types and the number of cells surviving was monitored in
the presence or absence of 100 ng/ml addit Fe31. GRPs were plated
n DMEM-BS supplemented with 1 ng/ml bFGF and O-2A/OPCs
ere plated in DMEM-BS containing 0.1 ng/ml PDGF and cultured
or 2 days. Oligodendrocytes were derived from progenitor cells and
lated in DMEM-BS supplemented with 45 nM T3. These cells
ere followed for 5 days after plating. The number of surviving
ells in each condition was determined by staining the cultures
ith MTT. Entire coverslips were counted for the number cells
taining. Note: The basic conditions chosen for each cell type
iether lead to proliferation nor differentiation during the time
eriod tested in the presence or absence fo high iron.between control cultures and those treated with additional
Copyright © 2001 by Academic Press. All rightiron. We also did not observe an increase in the total
number of progenitor cells during the 2-day period. This
suggests that additional iron does not lead to cell prolifera-
tion in the absence of adequate mitogens. The result also
demonstrates that the exposure of GRP, O-2A/OPC cells,
and oligodendrocytes to an additional 100 ng/ml iron had
no toxic effect to any of the cell populations tested.
To confirm that the cells used in this study (O-2A/OPC
and oligodendrocytes) were actually able to take up the iron
that we exogenously supplied in the medium, we used
atomic adsorption spectroscopy (AAS) to determine the
soluble iron contents in lysates of cells exposed a total of
114 ng/ml iron (5100 ng/liter additional iron over basal
levels) versus 14 ng/ml (5basal levels) of iron over 48 h. The
results showed that the O-2A/OPC cells shifted from 71.8
ng Fe/mg of protein to 196.4 ng Fe/mg protein during this
time period of iron exposure. The oligodendrocytes showed
a shift in soluble iron from 36.9 ng Fe/mg protein to 83.7 ng
Fe/mg protein when exposed to 100 ng/ml iron for 48 h.
There are two major events that could alter the behavior
of precursor cells in a way that would ultimately lead to
myelin deficiency. First, alteration of the proliferation rate
of the precursor cell pool could impact on the total number
of oligodendrocytes generated. Second, alteration of the
ability of precursor cells to differentiate into myelin pro-
ducing cells could also influence the number of oligoden-
drocytes. We started our examination of the effects of in
vitro iron availability with the earliest cell committed to
the generation of glia, the glial restricted precursor (GRP
cell).
Additional Iron Availability Decreases the
Proliferation of GRP Cells
GRP cells were isolated from the spinal cords of E13.5
rats, purified, and grown in culture for 10 days in the
presence of bFGF (10 ng/ml) which is the major mitogen for
these cells (Rao et al., 1998). As we have seen from our
survival experiments, additional iron has no effect on cell
proliferation in the absence of sufficient mitogens. To test
the hypothesis that iron might modulate the behavior of
proliferating cells, we replated GRP cells onto glass cover-
slips in the presence of 10, 50, and 100 ng/ml additional iron
and in the continued presence of 10 ng/ml bFGF. The
cultures were maintained in these conditions for 24 h with
BrdU being present at 10 mM in the cultures for the last 8 h.
The cultures were then stained with A2B5 and anti-BrdU
antibodies. The number of cells labeling for A2B5 and the
number of cells labeling for both A2B5 and BrdU were then
determined by manual counting. The percentage of A2B5-
positive cells labeling for BrdU was then calculated (Fig. 4).
It should be emphasized that although GRP cells can
generate O-2A/OPC cells, the culture condition used in this
experiment prevents the transition from GRP to O-2A/OPC
cells (Gregori et al., unpublished observation), maintaining
a population of homogenous (99%) tripotential GRP cells
(Rao et al., 1998). The data show that 100 ng/ml iron
s of reproduction in any form reserved.
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237Effect of Iron of Embryonic Glial Differentiationsignificantly affects the proliferation of GRP cells in the
presence of a mitogenic stimulus leading to a decrease in
the number of cells incorporating BrdU.
Effect of Additional Iron Availability on the
Differentiation of GRP Cells
The differentiation of progenitor cells into oligodendro-
cytes is marked by the expression of stage-specific antigens
(Dubois et al., 1990; Gard and Pfeiffer, 1990; Raff et al.,
978, 1983b, 1984; Sommer and Schachner, 1981). As GRPs
nd O-2A/OPCs differentiate into postmitotic oligodendro-
ytes, they can be labeled with an antibody galactocerebro-
ide (GalC) (Dubois et al., 1990; Gard and Pfeiffer, 1990;
aff et al., 1978, 1983b, 1984; Sommer and Schachner,
981). The expression of this specific antigen enabled us to
ollow the generation of oligodendrocytes in vitro.
GRP cells were isolated from the spinal cord of E13.5 rats
nd expanded for 10 days in the presence of 10 ng/ml bFGF.
he GRPs were then replated into a medium containing
hyroid hormone (45 nM) to promote oligodendrocyte dif-
erentiation for 5 or 7 days. Coverslips were stained with
2B5 (progenitor cells) and anti-GalC (oligodendrocytes)
FIG. 4. Increased iron availability alters the division of GRP cells.
Ten-day-old purified glial restricted precursors (GRPs) were plated
onto fibronectin/laminin-coated coverslips in DMEM-BS contain-
ing 10 ng/ml bFGF. Iron in the form of ferric ammonium citrate
was added after 24 h at 10, 50, and 100 ng/ml (the added iron is in
addition to the level of baseline iron concentration of 14 ng/ml
present in the defined medium). Control cultures did not receive
any additional iron. After an additional 16 h, 10 mM/ml BrdU was
added to all cultures. Coverslips were stained for A2B5 and BrdU
8 h after BrdU was added to the cultures. Entire coverslips were
counted for the number of A2B51 cells and for the number of
A2B51 cells that incorporated BrdU. The percentage of A2B51 cells
hat incorporated BrdU was then calculated.ntibodies. The number of cells staining for each antibody
Copyright © 2001 by Academic Press. All rightere counted and the percentage of oligodendrocytes deter-
ined. We found that a significantly higher percentage of
he GRP cells generated oligodendrocytes in the presence of
ron compared to controls (P , 0.05) (Fig. 5).
Additional Iron Availability and the Division of
O-2A/OPCs
The next cell in the oligodendroglial lineage that we
examined was the O-2A/OPC. Using much the same meth-
ods as were used in the study of GRP cells, we assayed the
effect of additional iron availability on the division of
O-2A/OPC cells and on the ability of O-2A/OPC cells to
differentiate into myelin-producing cells.
BrdU incorporation experiments, similar to those used to
examine the proliferation of GRP cells, were carried out in
the following manner. O-2A/OPC cells were cultured in a
medium supplemented with PDGF (10 ng/ml) and varying
levels of iron for 24 h with BrdU being present for the final
8 h. The cultures were stained with A2B5 (labeling progeni-
tors) and anti-BrdU antibodies (Fig. 6). The data clearly
show that the percentage of cells replicating their DNA
during the labeling period is decreased in a dose-dependent
manner in respect to additional iron.
Because the O-2A/OPC and GRP responded in a similar
manner to iron in respect to cell proliferation but differed in
the subsequent differentiation into oligodendrocytes (see
Fig. 8), we further examined how the increased iron avail-
ability was effecting the division of O-2A/OPCs. In order to
FIG. 5. Increased iron availability promotes the generation of
oligodendrocytes from GRP cells. Ten-day-old GRPs were plated on
fibronectin/laminin-coated coverslips in DMEM-BS supplemented
with 10 ng/ml bFGF, 45 nM T3, and 0 or 100 ng/ml additional Fe31.
After 5 days in culture, the coverslips were removed from culture
and stained for A2B5 and GalC. Whole coverslips were then
counted to determine the number of cells labeling for each antigen
and the percentage of GalC-positive cells (oligodendrocytes) was
then determined.
s of reproduction in any form reserved.
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238 Morath and Mayer-Pro¨schelsee whether the alteration in division was specific to iron
and reversible, we used the iron chelator desferrioxamine
mesylate (Dfx). Cultures were supplemented with iron
and/or Dfx for 24 h with BrdU present for the final 8 h. The
addition of the Dfx was able to abrogate the effect of
additional iron on BrdU incorporation (Fig. 6) and Dfx alone
had no effect on the incorporation of BrdU.
To differentiate between the possibilities of a general
slowing of cell cycle time and fewer cells proceeding
through the cell cycle, time-lapse microcinematography
was performed. Average cell cycle times were gathered from
the videos by following the divisions of daughter cells from
a first observable division. Average cell cycle times were
similar for cells in the presence or absence of increased iron
availability (Fig. 7).
These data show that additional iron affects the division
of the O-2A/OPC in a very specific manner. Though the
additional iron does affect the rate of progression through
the cell cycle, it does not lengthen but shortens the cell
cycle time of the cells cultured in the presence of additional
iron. Taken together the BrdU incorporation data and the
time-lapse study, we conclude that although cells divide
faster in the presence of high iron, the total number of cells
engaging in proliferation is lower when high iron is present.
Additional Iron Availability and the
Differentiation of O-2A/OPCs
To determine whether O-2A/OPCs progenitor cells re-
spond in the same manner to increased iron availability as
GRP cells in respect to differentiation, we isolated O-2A/
OPCs from the postnatal day-7 corpus callosum and plated
the cells in defined medium that was supplemented with a
FIG. 6. Increased iron availability alters the division of O-2A/OPCs
containing 10 ng/ml PDGF. Various experimental concentrations
desferioxamine mesylate (Dfx) were also added after 24 h. After an add
xposed to BrdU for 8 h, cultures were stained with A2B5 and anti-BrdU
nd for the number of A2B51 cells that incorporated BrdU. The per
mount of shading represents the amount of iron added to the cultur. Purified O-2A/OPCs were plated onto PLL-coated coverslips in medium
of iron in the form of ferric ammonium citrate or the iron chelator
itional 16 h, 10 mM/ml BrdU was added to all cultures. After the cells were
antibodies. Entire coverslips were counted for the number of A2B51 cells
centage of A2B51 cells that incorporated BrdU was then calculated. Thelow dose of PDGF (1 ng/ml) and thryoid hormone to allow
Copyright © 2001 by Academic Press. All rightFIG. 7. Increased iron availability does not alter cell cycle time.
O-2A/OPCs isolated from the corpus collosum of postnatal day 7 rat
pups were plated into T-75 flasks coated with PLL and cultured in
DMEM-BS containing 10 ng/ml PDGF. After allowing the cells to
adhere to the flask, they were placed in a heated (37°C), humidified,
CO2 regulated (7.5%) chamber built into the stage of a specially
converted Zeiss Axiovert 135 TV. Images were taken at an interval of
1 per second by using a Photometrics Image Point cooled CCD video
camera and a Panasonic AG-6730 time lapse video cassette recorder
for 72 h at 4003 magnification. The resulting video was analyzed by
following the daughters of a first observable division and timing the
interval to the next division. Easch point represents the time to
division from an original founding division to a daughter cell. A
minimum of 10 original founding divisions was followed in each
experiment.
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239Effect of Iron of Embryonic Glial Differentiationdifferentiation into oligodendrocytes. We then supple-
mented the basal differentiation condition with 100 ng/ml
additional iron (to a maximal concentration of 114 ng/ml).
It should be emphasized that in the culture conditions
chosen for that experiment cells do not undergo division
due to a lack of sufficient mitogens. This decrease in
mitogenic stimuli allows us therefore to separate the effects
additional iron has on division from any possible effect on
differentiation.
After time points ranging from 5 to 11 days, we deter-
mined the number of oligodendrocytes by staining with the
oligodendrocyte-specific marker anti-GalC. Cultures grown
in the absence or presence of additional iron did not show
any significant difference in the number of cells in a culture
that had differentiated into oligodendrocytes (P . 0.05) (Fig.
). These data suggest that the additional iron, which is
vailable during the peak phase in iron uptake, does not
lter the number of O-2A/OPCs that differentiate into
ligodendrocytes.
Maturation of Oligodendrocytes
To this point, we have established that the availability of
additional iron has profound effects on both GRP cells and
O-2A/OPC cells. We next wanted to establish the effects of
additional iron on the postmitotic progeny of the precursor
cells, the oligodendrocytes. Once glial precursor cells can be
labeled with the antibody GalC they represent oligodendro-
FIG. 8. Increased iron availability does not alter the generation of
oligodendrocytes from O-2A/OPCs. Purified O-2A/OPCs were
plated onto PLL-coated coverslips in medium containing 0.1 ng/ml
PDGF. After 24 h, various experimental concentrations of iron
were added to the cultures. Cultures were given an additional 0.1
ng/ml PDGF every 24 h. Coverslips were removed from culture and
immunocytochemically processed for A2B5 and GalC at days 5, 7,
9, and 11. The number of A2B51 and GalC1 cells on each coverslip
was counted and the number of GalC1 cells was calculated. At
every time point examined, there was no significant difference (P .
0.05) between those cultures with 100 ng/ml iron added and those
without added iron.cytes that have reached a stage where the cells no longer
Copyright © 2001 by Academic Press. All rightivide in the conditions used in our experiments. The cells
roceed through a maturation program to establish the
yelin-producing cell population. The maturation of oligo-
endrocytes from nonmyelin-producing cells to myelin-
roducing cells can be recognized by labeling cells with a
pecific antibody to myelin basic protein (MBP), a late-stage
yelin-specific protein. The following experiments were
erformed to determine whether the addition of iron to
reshly formed oligodendrocytes plays a critical role in the
aturation and myelin-forming capacity of the cells.
Cultures of immature oligodendrocytes were cultured for
or 7 days in the presence or absence of additional iron. The
ultures of oligodendrocytes showed no significant differ-
nce in the number of mature oligodendrocytes whether
dditional iron was present or absent (Fig. 9). This result
uggests that oligodendrocytes do not require the additional
ron (such as might be available during the peak phase in
ron uptake seen in vivo) in order to mature to the stage of
BP synthesis.
While the number of mature oligodendrocytes is the
ame in both the low and high iron conditions, there is the
lternate possibility that the iron may be affecting the
mount of myelin that these oligodendrocytes are able to
roduce. To test this possibility, we established pure oligo-
endrocyte cultures and exposed an equal number of cells
o either control conditions or medium supplemented with
FIG. 9. Increased iron availability does not alter oliodendrocyte
maturation. Immature oligodendrocytes were generated from
O-2A/OPCs isolated from the P7 corpus callosum by culturing the
cells on PLL-coated glass coverslips in the presence ofr T3. The
purity of the cultures was established by staining control coverslips
with A2B5 and GalC. Iron (100 ng/ml) was then added to the
experimental cultures. Cultures were grown for an additional 5 or
7 days and then stained for GalC and MBP. The number of cells
staining for GalC and the number staining for both GalC and MBP
was then determined by manually counting the coverslips. The
number of oligodendrocytes that express MBP was then deter-
mined.
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240 Morath and Mayer-Pro¨scheladditional iron. The cells were harvested after 3 days, and a
Western blot analysis against three myelin-specific pro-
teins, proteolipid protein, myelin basic protein, and 29,
39-cyclicnucleotide 39-phosphodiesterase (Campagnoni,
1988), was performed by using equalized amounts of pro-
teins. The experiment (Fig. 10) shows that in control and
experimental cultures the relative levels of all three
myelin-specific proteins were unchanged by exposure to
additional iron. This result suggests that oligodendrocytes
exposed to a low iron medium still have as much capacity
to generate all the important myelin components in vitro as
hose cells exposed to physiological amounts of iron at the
ime of greatest myelination.
DISCUSSION
In this study, we demonstrate that iron availability
modulates the generation of oligodendrocytes from tripo-
tential GRP cells isolated from the E13.5 rat spinal cord. In
contrast, we found no effects of iron on oligodendrocyte
maturation or survival, nor did we find that increasing iron
availability above basal levels increases oligodendrocyte
generation from bipotential O-2A/OPC cells. We did find
that increased iron availability lowered the number of
O-2A/OPC cells proceeding through the cell cycle without
changing the percentage of cells differentiating.
The lack of changes in oligodendrocyte survival and
maturation and O-2A/OPC differentiation are surprising.
The published data in the literature strongly suggested that
this period in myelin production would be where iron
played an important role. Our experiments, however, do not
support the suggestion that increased iron availability plays
a critical role in the survival and maturation of oligoden-
drocyte. The lack of a measurable impact of additional iron
FIG. 10. Increased iron availability does not change the amoun
oligodendrocytes were treated with 100 ng/ml additional Fe31 for 72
blotted to nitrocellulose. Blots were then probed with antibodies
proteolipid protein. Blots were then probed with proper HRP-con
Quantification and images were gathered with a luminometer.on oligodendrocyte cultures was not due to a possible e
Copyright © 2001 by Academic Press. All rightailure in iron uptake. We confirmed that the additional
ron supplied in the medium was actually taken up by
ligodendrocytes and their precursors but did not influence
he survival or maturation processes. With our assay sys-
em we, however, cannot rule out that increased iron
vailability might play a role in proper formation and
unction of myelin sheaths. It has, however, been reported
hat a lack of iron, leading to dysmyelination, seems not to
ffect the function of the remaining oligodendrocytes
resent. In these studies, myelin formation and wrapping
ppeared normal (de los Monteros et al., 2000; Larkin and
ao, 1990) raising the possibility that the importance of
ron may manifest itself at a stage of oligodendrocyte
evelopment prior to myelin production.
We also did not detect an effect on the generation of
ligodendrocytes from differentiating postnatal-derived
-2A/OPC cells. We could, however, establish a robust
ffect of additional iron on the proliferation of the O-2A/
PC population. This was surprising as in most experimen-
al paradigms using this cell culture system it has been
stablished that any changes in the proliferation rate of the
ells are usually linked to changes in the differentiation of
he progenitor cell pool into postmitotic oligodendrocytes
Mayer et al., 1993). The addition of iron, however, to
postnatal-derived O-2A/OPC cells seem to “unlink” these
two processes. Time-lapse microscopy analysis revealed
that O-2A/OPC cells exposed to high iron were dropping
out of division without a corresponding initiation of differ-
entiation. This leads to the suggestion that increased iron
levels, such as might be found during the peak in iron
uptake, may be a way of limiting the number of cells
capable of generating an oligodendrocyte in preparation for
differentiation without promoting the actual transition.
The uncoupling of division and differentiation has been
observed in experiments by Tikoo et al. (1998) where the
myelin-specific proteins produced by oligodendrocytes. Mature
ior to lysis in an NP40 buffer. Lysates were separated by PAGE and
elin basic protein, 2939-cyclic nucleotide 39 phosphodiesterase, or
ed secondary and visualized using chemiluminescence detection.t of
h pr
to ny
jugatctopic overexpression of p27 in O-2A progenitors led to a
s of reproduction in any form reserved.
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241Effect of Iron of Embryonic Glial Differentiationchange in proliferation without affecting the differentiation
outcome. We also observe a change in proliferation without
an effect on differentiation when we expose O-2A/OPC
cells to high iron. There is the possibility that these two
events are functionally linked. The addition of iron might
be changing p27 levels in the cells. Iron is a pro-oxidant and
a known inducer of oxidative stress through its ability to
participate in the formation of free radicals. Pro-oxidant
have been shown to up-regulate p27 in O-2A/OPC cells (M.
Noble, personal communication), which could lead in prin-
cipal to a similar outcome observed by the overexpression
of p27. In addition, the cell cycle arrest we see in high iron
may also occur through the redox sensitive p21 pathway or
through any of the other repair pathways that may be
activated by iron induced oxidative damage (Anderson et
l., 1998; Russo et al., 1995).
In contrast to postnatal O-2A/OPCs, additional iron
resent in cultures of GRPs was seen to significantly raise
he percentage of oligodendrocytes that developed in cul-
ure. The difference in iron response between O-2A/OPCs
nd GRP cells may have several causes. The genetic
witches that govern the differentiation of these precursors
ay respond differently to iron levels. Iron is known to
egulate the transcription and translation of many genes
nd there may be cell type specific differences in the targets
nd regulation of this system (Leibold and Guo, 1992).
Another possibility is that there is a threshold iron level
hat must be reached for a precursor to differentiate into an
ligodendrocyte. The lack of a differentiation effect on the
ostnatal O-2A/OPCs could be a result of the threshold iron
oad already being met in these cells. GRPs on the other
and are much younger cells and have not had the oppor-
unity to load iron. The additional iron in the culture media
ould then provide the necessary iron these cells need to
ross the threshold into a state of competency to generate
n oligodendrocyte.
The possibility remains that the differences seen between
RP cells and O-2A/OPCs is due to differences in the
inimal growth factors required by each cell type. The
onditions for each cell type were designed as to be optimal
or survival so that cell death would not be a confounding
actor in analyzing the final percentage of differentiated
ells. bFGF is required for GRP survival but this same
rowth factor prevents the differentiation of O-2A cells into
ligodendrocytes so it could not be used in an experiment
esting the effects of iron on the differentiation of O-2As
Bogler et al., 1990). Further experiments will be required to
nderstand these paradoxical results.
The observation that high iron does only promote the
eneration of oligodendrocytes from GRP cells but not from
solated O-2A/OPC together with our results showing that
RP cells can actually give rise to O-2A/OPC cells, suggest
et another the possible role of iron: iron might directly be
nvolved in promoting the transition of GRP cells to O-2A/
PC cells therefore contributing to an increase in the
-2A/OPC cell pool that is then responsible for generating
ligodendrocytes. Alternatively, it might be possible that
Copyright © 2001 by Academic Press. All rightRP cells can generate oligodendrocytes without proceed-
ng through an O-2A/OPC stage, in which case one could
rgue that the mechanism by which iron can promote the
eneration of GRP cells to oligodendrocytes is different
han the generation of oligodendrocytes from O-2A/OPCs
hat seem unresponsive to iron. We are in the process of
dentifying selective markers that can distinguish GRP
rom O-2A/OPCs and are not expressed by oligodendrocytes
t any stage. This approach will allow us to ablate specific
opulations by complement depletion allowing us to study
he role of iron in the regulation of lineage progression in
ore detail.
Taken together, we have identified an embryonic time
oint in the development of oligodendrocytes that is sensi-
ive to iron levels. While the significantly increased levels
f oligodendrocytes generated from GRP cells in response to
igh iron appear moderate, this difference may be substan-
ial when viewed in the context of iron deficiency.
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